5 Biotech Penny Stocks to Buy Now

Page 5 of 5

1. Leap Therapeutics, Inc. (NASDAQ:LPTX)

Number of Hedge Fund Holders: 21    

Leap Therapeutics, Inc. (NASDAQ:LPTX) is a biopharma firm focusing on the development of treatments for cancer. The company has a market cap of $224 million and was founded in 2011. The 52-week price range of the stock lies between $1.3 and $4.1. 

Mizuho analyst Mara Goldstein recently initiated coverage of Leap Therapeutics, Inc. (NASDAQ:LPTX) stock with a Buy rating and a price target of $6, appreciating the development of pipeline drugs of the company. 

At the end of the third quarter of 2021, 21 hedge funds in the database of Insider Monkey held stakes worth $115 million in Leap Therapeutics, Inc. (NASDAQ:LPTX), up from 9 the preceding quarter worth $23 million.

You can also take a peek at 10 Best Medical Stocks Under $10 and 15 Best Warren Buffett Stocks to Buy Now.

Page 5 of 5